VYNE (STOCKS)
VYNE Therapeutics Inc. Common Stock
$0.624800
+0.014800 (+2.43%)
Prev close: $0.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Domzalski
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.66M
- Employees
- 13
- P/E (TTM)
- -0.96
- P/B (TTM)
- 0.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.11 | $-0.18 | +0.0707 | +38.50% |
|
Sep 2025 (Q3)
|
$-0.17 | $-0.13 | -0.0374 | -28.21% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.23 | +0.0978 | +42.93% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.30 | +0.0958 | +32.39% |
Financial Statements
| Revenues | $570.00K |
| Benefits Costs and Expenses | $27.30M |
| Costs And Expenses | $30.32M |
| Operating Expenses | $30.32M |
| Research and Development | $19.24M |
| Other Operating Expenses | $11.08M |
| Operating Income/Loss | -$29.75M |
| Income/Loss From Continuing Operations After Tax | -$26.74M |
| Income/Loss From Continuing Operations Before Tax | -$26.73M |
| Income/Loss From Discontinued Operations Net Of Tax | $253.00K |
| Income Tax Expense/Benefit | $4.00K |
| Income Tax Expense/Benefit, Current | $4.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$26.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.62 |
| Diluted Earnings Per Share | -$0.62 |
| Basic Average Shares | 42,768,000 |
| Diluted Average Shares | 42,768,000 |
| Assets | $30.16M |
| Current Assets | $30.01M |
| Noncurrent Assets | $150.00K |
| Fixed Assets | $90.00K |
| Other Non-current Assets | $60.00K |
| Liabilities | $2.40M |
| Current Liabilities | $2.40M |
| Wages | $413.00K |
| Other Current Liabilities | $1.98M |
| Noncurrent Liabilities | $0.00 |
| Long-term Debt | $0.00 |
| Equity | $27.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.77M |
| Liabilities And Equity | $30.16M |
| Net Cash Flow From Operating Activities | -$33.12M |
| Net Cash Flow From Operating Activities, Continuing | -$33.12M |
| Net Cash Flow From Investing Activities | $37.37M |
| Net Cash Flow From Investing Activities, Continuing | $37.37M |
| Net Cash Flow From Financing Activities | -$143.00K |
| Net Cash Flow From Financing Activities, Continuing | -$143.00K |
| Net Cash Flow | $4.10M |
| Net Cash Flow, Continuing | $4.10M |
| Comprehensive Income/Loss | -$26.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.50M |
| Other Comprehensive Income/Loss | -$18.00K |